Tigris Pharmaceuticals is actively seeking to in-license or acquire molecules for specialty care markets with one of the following characteristics: Approved molecules that can be reformulated or repositioned to fulfill critical medical needs Stalled late stage development programs NDAs that are facing regulatory challenges Tigris has expertise in developing breakthrough products/technologies in all stages of development, including pre-clinical, early- and late-stage clinical development. Our team offers decades of experience in clinical drug development and regulatory affairs, and a track record of gaining FDA and worldwide approvals for multiple oncology products. Our leadership team alone has achieved approval of 9 product indications worldwide and led the initiation of hundreds of clinical trials. If you are interested in working with Tigris Pharmaceuticals, please contact us directly at: partnering@tigrispharma.com.